275 related articles for article (PubMed ID: 33834266)
1. Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.
Kratzer K; Getz LJ; Peterlini T; Masson JY; Dellaire G
Hum Genet; 2022 Jun; 141(6):1175-1193. PubMed ID: 33834266
[TBL] [Abstract][Full Text] [Related]
2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
Sarkar E; Khan A
Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
[TBL] [Abstract][Full Text] [Related]
5. Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
Isa NM; Zulkifli NA; Man S
Sci Eng Ethics; 2020 Feb; 26(1):309-323. PubMed ID: 30830592
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
8. Various Aspects of a Gene Editing System-CRISPR-Cas9.
Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
[TBL] [Abstract][Full Text] [Related]
9. Advances in Genetic Editing of the Human Embryo.
Astarăstoae V; Ioan BG; Rogozea LM; Hanganu B
Am J Ther; 2023 Mar-Apr 01; 30(2):e126-e133. PubMed ID: 36762925
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and diagnostic relevance of Crispr technology.
El Ouar I; Djekoun A
Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 gene editing induced complex on-target outcomes in human cells.
Wen W; Zhang XB
Exp Hematol; 2022 Jun; 110():13-19. PubMed ID: 35304271
[TBL] [Abstract][Full Text] [Related]
13. A new era of gene editing for the treatment of human diseases.
Kc M; Steer CJ
Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
[TBL] [Abstract][Full Text] [Related]
14. Human embryo gene editing: God's scalpel or Pandora's box?
Zhou Q; Zhang Y; Zou Y; Yin T; Yang J
Brief Funct Genomics; 2020 May; 19(3):154-163. PubMed ID: 32101273
[TBL] [Abstract][Full Text] [Related]
15. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
[TBL] [Abstract][Full Text] [Related]
16. [Control (editing) of the genome within reach, or already in our hands?].
Brdička R; Omelka R
Cas Lek Cesk; 2018; 157(2):79-83. PubMed ID: 29790357
[TBL] [Abstract][Full Text] [Related]
17. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma.
Hong L; Zhang C; Jiang Y; Liu H; Huang H; Guo D
Future Oncol; 2020 Jun; 16(16):1125-1136. PubMed ID: 32338048
[TBL] [Abstract][Full Text] [Related]
19. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
20. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
